BRAF and melanoma: The aim of this study was to investigate the value of magnetic resonance spectroscopy (MRS) of choline and diffusion-weighted magnetic resonance imaging (DW-MRI) as early markers of response or resistance to targeted therapies for the treatment of BRAF mutated melanoma.